![](https://endpts.com/wp-content/uploads/2022/12/Adam-Simpson-Icosavax-HQ-tile.jpg)
Adam Simpson, Icosavax CEO
Icosavax pushes forward combo RSV-hMPV vaccine and announces direct stock offering
Seattle-based Icosavax may have failed in its attempt at a Covid-19 vaccine in 2022, but it released early data on its bivalent vaccine candidate for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.